Subscribe to Newsletter
Business & Regulation Standards & Regulation, Trends & Forecasts

Reactions to the Nomination of Robert F Kennedy Jr. as US Health Secretary

By now you’ll all have heard the news: Donald Trump has nominated Robert F Kennedy (RFK) Jr. to lead the Department of Health and Human Services, although the decision still needs to be endorsed by the Senate. RFK Jr.’s name was widely touted as a potential candidate before the outcome of the election, but many were still surprised that Trump actually went ahead with it – including Trump-appointed former FDA Commissioner and Pfizer board member Scott Gottlieb, who said that Kennedy’s confirmation will “cost lives in this country”.

Democrats have been swift to voice their opinion. Here’s a selection of their reactions:



A number of scientists have also expressed concern. For example:

David Elliman, Consultant Paediatrician, Great Ormond Street Hospital for Children:

“The news that Donald Trump will be nominating Robert F Kennedy for US Secretary of Health and Human Services is very worrying. While RFK Jr.’s desire to tackle chronic conditions, including obesity, is commendable, how he might go about it is less clear.

“In his earlier days, he was an ardent conservationist, which is to be applauded. What is really concerning are his views on vaccination. He has perpetuated myths, including that of a link between MMR vaccine and autism, with an utter disregard for the evidence. If he is appointed and continues in the same mode, I fear not just for the vaccination programme in the USA, but similar programmes around the world, and for healthcare, in general. Vaccination has probably saved more lives and is better researched than most, if not all, aspects of healthcare. RFK Jr. could set this back and be responsible for the death and disability of myriads of people, particularly children.

“Let us hope that, if appointed, he adopts a more responsible attitude. Directing his energies to the ‘industrial food complex’ would be no bad thing, as would ensuring more transparency from pharmaceutical companies.”

NEWS

The Medicine Maker Presents:

The Medicine Maker Newsletter

Enjoying yourself? There's plenty more where that came from! Our weekly Newsletter brings you the most popular stories as they unfold, chosen by our fantastic Editorial team!

Register for our weekly newsletter

When it comes to pharmaceutical stakeholders, some responses have been diplomatic, with PhRMA confirming that they “want to work with the Trump administration” to iron out any flaws in Biden’s flagship Inflation Reduction Act. The biotechnology Innovation Organization (BIO) also looks forward “to working closely with President-elect Trump, his incoming Administration, and members of Congress.” Elsewhere, the American Association Public Health Association (APHA) was not so optimistic, suggesting that “The American people deserve better than Mr. Kennedy”.

Born on January 17, 1954, RFK Jr. is the third of 11 children of Senator Robert F. Kennedy and Ethel Skakel Kennedy, and he is a nephew of President John F. Kennedy. Having earned a bachelor's degree from Harvard University in 1976, a Juris Doctor from the University of Virginia School of Law, and a Master of Laws in environmental law from Pace University, Kennedy is an established environmental attorney, author, and activist. He served as chief prosecuting attorney for the Hudson Riverkeeper and as president of the Waterkeeper Alliance. His reputation carries a fearlessness in bringing environmental lawsuits to major global corporations.

More recently, Kennedy has become skeptical about vaccines and the big pharmaceutical stakeholders that manufacture them, founding the World Mercury Project (later known as the Children's Health Defense), an organization known for its anti-vaccine stance. Having now found his way into the role of United States Secretary of Health and Human Services, pending Senate confirmation, he has returned the Kennedy family to mainstream politics, but we await the effects of this nomination – for good or ill – with interest. 





Co-President of Public Citizen Robert Weisman has suggested Kennedy “shouldn’t be allowed in the building at the Department of Health and Human Services (HHS), let alone be placed in charge of the nation’s public health agency.” Keck Medicine professor Apu Akkad described the nomination on a “scary day for public health”.

It is undoubtedly an unconventional nomination, tinged – as with many of Trump’s strategies – with a hint of divisiveness, yet there is more than vaccine skepticism at play. Kennedy’s ruthless pursuit for corporate justice and vociferous opposition to corruption and cronyism could be a good thing for regulatory organizations, according to David Nunan, Senior Research Fellow at the Centre for Evidence Based Medicine, University of Oxford: “One of the key issues Robert F. Kennedy Jr. raises is the need to address the ‘revolving door’ phenomenon within key health organizations like the FDA. This practice, where leaders transition directly into high-paying consultancy roles for companies regulated by the FDA, creates clear conflicts of interest. His stance on ending this cycle is a point many can agree on, as it would strengthen the integrity of these health institutions.”

Though Nunan’s statement reads like a vindication for RFK Jr.’s nomination, his point is one that stresses the importance of institutional reform, rather than approval of the harbinger of that reform, concluding his statement by suggesting Kennedy is not the right man for the job. Democratic Colorado Governor Jared Polis, however, disagrees. Indeed, Polis has expressed excitement for the nomination and believes Kennedy will spearhead the legal actions that will ultimately “improve our health.”

It is difficult to find approval from anyone outside of Trump’s immediate circle (we tried), but whether people agree or disagree with the choice, everybody’s talking about it.

It would be great to hear what you’ve been discussing, so get in touch with your thoughts, ideas, and opinions.

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Authors
Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.


Rob Coker

Deputy Editor of The Medicine Maker

Following a Bachelor’s degree in English Literature and a Master’s in Creative Writing, I entered the world of publishing as a proofreader, working my way up to editor. The career so far has taken me to some amazing places, and I’m excited to see where I can go with Texere and The Medicine Maker.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register